Replies to post #368 on CVR Medical Corp (CRRVF)

[nugnug]

De Nova (of new) for a brand new device class is still issued a timeframe for review set at 120 FDA days. And who knows what "FDA days" means. I hope you are right. I am just being cautious with my expectations. Q1 rollout would be tremendous.